Sangamo Therapeutics Stock Current Ratio

SGMO Stock  USD 0.67  0.05  8.06%   
Sangamo Therapeutics fundamentals help investors to digest information that contributes to Sangamo Therapeutics' financial success or failures. It also enables traders to predict the movement of Sangamo Stock. The fundamental analysis module provides a way to measure Sangamo Therapeutics' intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Sangamo Therapeutics stock.
As of the 28th of March 2024, Current Ratio is likely to drop to 1.88.
  
This module does not cover all equities due to inconsistencies in global equity categorizations. Continue to Equity Screeners to view more equity screening tools.

Sangamo Current Ratio Analysis

Sangamo Therapeutics' Current Ratio is calculated by dividing the Current Assets of a company by its Current Liabilities. It measures whether or not a company has enough cash or liquid assets to pay its current liability over the next fiscal year. The ratio is regarded as a test of liquidity for a company.

Sangamo Therapeutics Current Ratio

1.88

Current Ratio

 = 

Current Asset

Current Liabilities

More About Current Ratio | All Equity Analysis

Current Sangamo Therapeutics Current Ratio

    
  2.86 X  
Most of Sangamo Therapeutics' fundamental indicators, such as Current Ratio, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Sangamo Therapeutics is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.

Sangamo Current Ratio Driver Correlations

Understanding the fundamental principles of building solid financial models for Sangamo Therapeutics is extremely important. It helps to project a fair market value of Sangamo Stock properly, considering its historical fundamentals such as Current Ratio. Since Sangamo Therapeutics' main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Sangamo Therapeutics' historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Sangamo Therapeutics' interrelated accounts and indicators.
0.97-0.40.890.620.970.730.420.410.890.970.03-0.780.630.510.810.890.350.670.830.890.670.070.320.720.90.740.37
0.97-0.310.810.560.890.640.320.540.910.97-0.1-0.740.50.420.70.850.390.590.730.890.580.10.240.650.90.760.23
-0.4-0.31-0.41-0.96-0.48-0.86-0.870.0-0.11-0.32-0.220.19-0.88-0.86-0.78-0.25-0.48-0.79-0.71-0.56-0.87-0.090.16-0.73-0.010.26-0.94
0.890.81-0.410.580.920.710.520.310.690.790.19-0.720.730.460.720.890.220.610.70.660.680.020.440.690.80.570.46
0.620.56-0.960.580.660.930.850.150.350.550.16-0.370.910.870.880.450.530.860.830.740.910.11-0.070.810.26-0.020.88
0.970.89-0.480.920.660.790.510.260.820.920.16-0.780.730.570.870.890.290.720.890.830.730.030.390.760.840.680.49
0.730.64-0.860.710.930.790.750.110.470.670.28-0.540.90.930.920.640.330.910.90.770.90.11-0.080.910.430.170.79
0.420.32-0.870.520.850.510.75-0.020.150.310.28-0.150.90.690.680.340.420.720.640.460.78-0.130.050.550.1-0.160.93
0.410.540.00.310.150.260.11-0.020.410.39-0.13-0.06-0.01-0.040.090.430.160.230.090.480.180.030.070.260.530.39-0.09
0.890.91-0.110.690.350.820.470.150.410.95-0.14-0.620.30.230.590.720.310.390.650.810.410.170.210.520.880.880.07
0.970.97-0.320.790.550.920.670.310.390.95-0.05-0.750.510.440.760.820.330.590.80.90.570.130.210.660.880.790.25
0.03-0.1-0.220.190.160.160.280.28-0.13-0.14-0.050.010.370.310.290.29-0.260.470.270.090.29-0.280.090.240.0-0.10.41
-0.78-0.740.19-0.72-0.37-0.78-0.54-0.15-0.06-0.62-0.750.01-0.46-0.4-0.61-0.77-0.11-0.46-0.61-0.58-0.440.1-0.33-0.49-0.73-0.61-0.15
0.630.5-0.880.730.910.730.90.9-0.010.30.510.37-0.460.810.870.570.360.850.820.610.89-0.070.180.740.320.030.92
0.510.42-0.860.460.870.570.930.69-0.040.230.440.31-0.40.810.80.460.320.880.790.60.80.12-0.240.840.18-0.080.75
0.810.7-0.780.720.880.870.920.680.090.590.760.29-0.610.870.80.650.370.880.980.840.860.090.20.830.520.320.76
0.890.85-0.250.890.450.890.640.340.430.720.820.29-0.770.570.460.650.090.680.70.710.58-0.180.370.640.910.710.29
0.350.39-0.480.220.530.290.330.420.160.310.33-0.26-0.110.360.320.370.090.250.320.50.490.360.020.330.07-0.040.37
0.670.59-0.790.610.860.720.910.720.230.390.590.47-0.460.850.880.880.680.250.880.760.85-0.150.020.810.440.170.77
0.830.73-0.710.70.830.890.90.640.090.650.80.27-0.610.820.790.980.70.320.880.850.810.040.170.820.580.430.69
0.890.89-0.560.660.740.830.770.460.480.810.90.09-0.580.610.60.840.710.50.760.850.740.140.070.770.70.550.47
0.670.58-0.870.680.910.730.90.780.180.410.570.29-0.440.890.80.860.580.490.850.810.740.030.030.880.380.10.87
0.070.1-0.090.020.110.030.11-0.130.030.170.13-0.280.1-0.070.120.09-0.180.36-0.150.040.140.03-0.210.31-0.11-0.07-0.07
0.320.240.160.44-0.070.39-0.080.050.070.210.210.09-0.330.18-0.240.20.370.020.020.170.070.03-0.21-0.070.430.390.04
0.720.65-0.730.690.810.760.910.550.260.520.660.24-0.490.740.840.830.640.330.810.820.770.880.31-0.070.470.230.65
0.90.9-0.010.80.260.840.430.10.530.880.880.0-0.730.320.180.520.910.070.440.580.70.38-0.110.430.470.920.02
0.740.760.260.57-0.020.680.17-0.160.390.880.79-0.1-0.610.03-0.080.320.71-0.040.170.430.550.1-0.070.390.230.92-0.23
0.370.23-0.940.460.880.490.790.93-0.090.070.250.41-0.150.920.750.760.290.370.770.690.470.87-0.070.040.650.02-0.23
Click cells to compare fundamentals

Sangamo Current Ratio Historical Pattern

Today, most investors in Sangamo Therapeutics Stock are looking for potential investment opportunities by analyzing not only static indicators but also various Sangamo Therapeutics' growth ratios. Consistent increases or drops in fundamental ratios usually indicate a possible pattern that can be successfully translated into profits. However, when comparing two companies, knowing each company's current ratio growth rates may not be enough to decide which company is a better investment. That's why investors frequently use a static breakdown of Sangamo Therapeutics current ratio as a starting point in their analysis.
   Sangamo Therapeutics Current Ratio   
       Timeline  
Typically, short-term creditors will prefer a high current ratio because it reduces their overall risk. However, investors may prefer a lower current ratio since they are more concerned about growing the business using assets of the company. Acceptable current ratios may vary from one sector to another, but the generally accepted benchmark is to have current assets at least as twice as current liabilities (i.e., Current Ration of 2 to 1).
Competition

Sangamo Short Term Coverage Ratios

Short Term Coverage Ratios

(46.55)

At this time, Sangamo Therapeutics' Short Term Coverage Ratios is very stable compared to the past year.
In accordance with the recently published financial statements, Sangamo Therapeutics has a Current Ratio of 2.86 times. This indicator is about the same for the Biotechnology average (which is currently at 2.91) sector and 59.14% lower than that of the Health Care industry. The current ratio for all United States stocks is 32.41% lower than that of the firm.

Sangamo Current Ratio Peer Comparison

Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Sangamo Therapeutics' direct or indirect competition against its Current Ratio to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Sangamo Therapeutics could also be used in its relative valuation, which is a method of valuing Sangamo Therapeutics by comparing valuation metrics of similar companies.
Sangamo Therapeutics is currently under evaluation in current ratio category among related companies.

Sangamo Fundamentals

About Sangamo Therapeutics Fundamental Analysis

The Macroaxis Fundamental Analysis modules help investors analyze Sangamo Therapeutics's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Sangamo Therapeutics using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Sangamo Therapeutics based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Last ReportedProjected for 2024
Current Ratio 1.98  1.88 
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Sangamo Therapeutics in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Sangamo Therapeutics' short interest history, or implied volatility extrapolated from Sangamo Therapeutics options trading.

Currently Active Assets on Macroaxis

When determining whether Sangamo Therapeutics offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Sangamo Therapeutics' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Sangamo Therapeutics Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Sangamo Therapeutics Stock:
Check out Sangamo Therapeutics Piotroski F Score and Sangamo Therapeutics Altman Z Score analysis.
To learn how to invest in Sangamo Stock, please use our How to Invest in Sangamo Therapeutics guide.
You can also try the Premium Stories module to follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope.

Complementary Tools for Sangamo Stock analysis

When running Sangamo Therapeutics' price analysis, check to measure Sangamo Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Sangamo Therapeutics is operating at the current time. Most of Sangamo Therapeutics' value examination focuses on studying past and present price action to predict the probability of Sangamo Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Sangamo Therapeutics' price. Additionally, you may evaluate how the addition of Sangamo Therapeutics to your portfolios can decrease your overall portfolio volatility.
Portfolio Suggestion
Get suggestions outside of your existing asset allocation including your own model portfolios
My Watchlist Analysis
Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like
Theme Ratings
Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance
Commodity Channel
Use Commodity Channel Index to analyze current equity momentum
Headlines Timeline
Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity
Idea Breakdown
Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes
Is Sangamo Therapeutics' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Sangamo Therapeutics. If investors know Sangamo will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Sangamo Therapeutics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(1.48)
Revenue Per Share
1.01
Quarterly Revenue Growth
(0.93)
Return On Assets
(0.18)
Return On Equity
(1.36)
The market value of Sangamo Therapeutics is measured differently than its book value, which is the value of Sangamo that is recorded on the company's balance sheet. Investors also form their own opinion of Sangamo Therapeutics' value that differs from its market value or its book value, called intrinsic value, which is Sangamo Therapeutics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Sangamo Therapeutics' market value can be influenced by many factors that don't directly affect Sangamo Therapeutics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Sangamo Therapeutics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Sangamo Therapeutics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Sangamo Therapeutics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.